Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-450/r and ABT-267 in Japanese Adults With Chronic HCV
NCT01672983Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of paritaprevir, ombitasvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Jul 2012; status: completed.
02
Drugs
paritaprevirombitasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01672983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672983.